| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/02/2008 | CA2677646A1 Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints |
| 10/02/2008 | CA2583658A1 Multi-carotenoids compositions and uses therefor |
| 10/01/2008 | EP1975620A2 Three hybrid assay system |
| 10/01/2008 | EP1975238A1 Gene construct, vector and dna vaccine for the vaccination of aquatic animals |
| 10/01/2008 | EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines |
| 10/01/2008 | EP1975177A1 An appetite-suppressing peptide, its compositions and use |
| 10/01/2008 | EP1975168A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 10/01/2008 | EP1975165A1 Substituted pyrrolidinamides, their production and utilisation as medicine |
| 10/01/2008 | EP1975164A2 Octahydrobenzimidazolone compounds as analgetics |
| 10/01/2008 | EP1975163A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection |
| 10/01/2008 | EP1975162A1 Oxazolone derivative |
| 10/01/2008 | EP1975161A1 Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments |
| 10/01/2008 | EP1975159A1 2,3,4,9-Tetrahydro-1H-carbazoles |
| 10/01/2008 | EP1975158A1 Novel pyrrole derivatives with histone deacetylase inhibitor activity |
| 10/01/2008 | EP1975153A2 Protease inhibitors |
| 10/01/2008 | EP1974752A1 Subcellular targeting of therapeutic proteins |
| 10/01/2008 | EP1974750A1 Preventive or therapeutic agent and method for immune disease |
| 10/01/2008 | EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis |
| 10/01/2008 | EP1974739A1 Methods and compounds for modulating inflammatory processes |
| 10/01/2008 | EP1974738A2 Diagnostics and therapeutics for glaucoma |
| 10/01/2008 | EP1974732A1 Therapeutic agent for neurodegenerative disease |
| 10/01/2008 | EP1974731A1 Antitussive agent |
| 10/01/2008 | EP1974730A1 Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| 10/01/2008 | EP1974729A1 Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists |
| 10/01/2008 | EP1974728A1 Lipid metabolism improving composition |
| 10/01/2008 | EP1974727A1 Therapeutic agent for acute cerebral infarct |
| 10/01/2008 | EP1974725A1 Sustained release preparation and method for production thereof |
| 10/01/2008 | EP1974724A2 Oral preparations with good disintegration |
| 10/01/2008 | EP1974722A2 Modified dosage forms of tacrolimus |
| 10/01/2008 | EP1974721A1 Injectable sterile pharmaceutical composition with piperacillin sodium and tazobactam sodium as active principles |
| 10/01/2008 | EP1974035A1 Interfering rnas targeting the morbillivirus nucleoprotein gene |
| 10/01/2008 | EP1973930A2 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 10/01/2008 | EP1973924A1 Amorphous telithromycin compound |
| 10/01/2008 | EP1973919A2 One pot synthesis of tetrazole derivatives of sirolimus |
| 10/01/2008 | EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 10/01/2008 | EP1973916A1 PYRROLO Ýl,2-A¨QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF |
| 10/01/2008 | EP1973915A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 10/01/2008 | EP1973914A2 Transforming growth factor modulators |
| 10/01/2008 | EP1973913A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 10/01/2008 | EP1973911A2 Azaindoles useful as inhibitors of janus kinases |
| 10/01/2008 | EP1973910A1 Pyrrolo ý3,2-c¨pyridine-4-one 2-indolinone protein kinase inhibitors |
| 10/01/2008 | EP1973909A2 Transforming growth factor modulators |
| 10/01/2008 | EP1973907A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 10/01/2008 | EP1973906A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
| 10/01/2008 | EP1973905A1 Compounds |
| 10/01/2008 | EP1973904A2 Muscarinic agonists and methods of use thereof |
| 10/01/2008 | EP1973903A1 Substituted 4-phenylpiperidines |
| 10/01/2008 | EP1973902A2 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 10/01/2008 | EP1973901A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 10/01/2008 | EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 10/01/2008 | EP1973898A1 Pdf inhibitors |
| 10/01/2008 | EP1973897A2 Substituted pyrymidine derivatives useful in the treatment of cancer and other disorders |
| 10/01/2008 | EP1973894A2 Method for preparation of amorphous, anhydrous crystalline, or hydrated crystalline docetaxel |
| 10/01/2008 | EP1973889A2 Cetp inhibitors |
| 10/01/2008 | EP1973887A1 Aza heterocyclics for the treatment of malaria or aids |
| 10/01/2008 | EP1973886A2 Prokineticin 1 receptor antagonists |
| 10/01/2008 | EP1973884A2 Novel heterocycles |
| 10/01/2008 | EP1973883A2 Novel compounds and methods for their production |
| 10/01/2008 | EP1973882A1 Piperazine derivatives as farnesyl protein transferase inhibitors |
| 10/01/2008 | EP1973880A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 10/01/2008 | EP1973876A2 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 10/01/2008 | EP1973875A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 10/01/2008 | EP1973872A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 10/01/2008 | EP1973871A1 Diphenyl urea derivatives |
| 10/01/2008 | EP1973868A1 Novel elatonin ligands having antidepressant activity as well as sleep inducing properties |
| 10/01/2008 | EP1973610A1 Use of polyunsaturated compounds as whitening agents |
| 10/01/2008 | EP1973569A2 Specific therapy using integrin ligands for treating cancer |
| 10/01/2008 | EP1973555A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts |
| 10/01/2008 | EP1973554A2 Cartilage repair methods |
| 10/01/2008 | EP1973552A2 Parenteral nutrition composition containing iron |
| 10/01/2008 | EP1973551A1 Method and composition for treating and diagnosing restless legs syndrome |
| 10/01/2008 | EP1973550A2 Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 10/01/2008 | EP1973549A2 Methods and compositions for administration of iron |
| 10/01/2008 | EP1973548A2 Soft protease inhibitors and pro-soft forms thereof |
| 10/01/2008 | EP1973547A1 Compounds having cytokine modulating properties |
| 10/01/2008 | EP1973545A2 Bicyclic heteroaryl compounds |
| 10/01/2008 | EP1973543A2 Modulators of muscarinic receptors |
| 10/01/2008 | EP1973542A2 Treatment of cachexia with statins |
| 10/01/2008 | EP1973541A2 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 10/01/2008 | EP1973540A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 10/01/2008 | EP1973539A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| 10/01/2008 | EP1973538A2 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 10/01/2008 | EP1973537A1 Carbamate antibiotics |
| 10/01/2008 | EP1973536A2 Treatment of fatty liver |
| 10/01/2008 | EP1973535A2 Method for the treatment of tinnitus |
| 10/01/2008 | EP1973532A1 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same |
| 10/01/2008 | EP1973528A2 Sustained-release formulations of topiramate |
| 10/01/2008 | EP1973524A1 Concentrated liquid thyroid hormone composition |
| 10/01/2008 | EP1973427A2 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers |
| 10/01/2008 | EP1973425A1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 10/01/2008 | EP1973423A1 Formulation comprising a polyphenol-containing composition and isomaltulose |
| 10/01/2008 | EP1973418A1 Novel use of a nutraceutical composition in animal feed |
| 10/01/2008 | EP1973409A2 Novel phytic citrate compounds and process for preparing the same |
| 10/01/2008 | EP1973407A2 Spiro compounds and methods of use |
| 10/01/2008 | EP1973405A2 Hydroxyalkylarylamide derivatives |
| 10/01/2008 | EP1973398A1 Use of inositol-tripyrophosphate in treating tumors and diseases |
| 10/01/2008 | EP1885363B1 Use of 3,11b-cis-dihydrotetrabenazine for the treatment of symptoms of huntington' s disease |
| 10/01/2008 | EP1765317B1 Materials and methods for improving shellfish health, immunity and growth |
| 10/01/2008 | EP1732922B1 Methods for minimizing thioamide impurities |
| 10/01/2008 | EP1713477B1 Combination of voriconazole and an antifungal cyp2c19 inhibitor |